Free Trial

Bausch Health Companies (BHC) Competitors

Bausch Health Companies logo
C$8.74 0.00 (0.00%)
As of 04:00 PM Eastern

BHC vs. APHA, PBH, AUP, CARA, SLS, CRON, TEV, ABT, NOT, and PYR

Should you be buying Bausch Health Companies stock or one of its competitors? The main competitors of Bausch Health Companies include Aphria (APHA), Premium Brands (PBH), Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), Solaris Resources (SLS), Cronos Group (CRON), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), and PyroGenesis Canada Inc. (PYR.V) (PYR). These companies are all part of the "pharmaceutical products" industry.

Bausch Health Companies vs. Its Competitors

Bausch Health Companies (TSE:BHC) and Aphria (TSE:APHA) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

In the previous week, Bausch Health Companies had 3 more articles in the media than Aphria. MarketBeat recorded 3 mentions for Bausch Health Companies and 0 mentions for Aphria. Aphria's average media sentiment score of 0.00 beat Bausch Health Companies' score of -0.14 indicating that Aphria is being referred to more favorably in the news media.

Company Overall Sentiment
Bausch Health Companies Neutral
Aphria Neutral

Given Aphria's higher possible upside, analysts clearly believe Aphria is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Aphria
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Aphria has a net margin of 0.00% compared to Bausch Health Companies' net margin of -1.88%. Bausch Health Companies' return on equity of 15.87% beat Aphria's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch Health Companies-1.88% 15.87% 4.16%
Aphria N/A N/A N/A

Bausch Health Companies has higher revenue and earnings than Aphria. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch Health CompaniesC$6.69B0.34-C$125.65M-C$0.68-12.79
AphriaC$611.06M0.00-C$637.39M-C$2.01N/A

79.0% of Bausch Health Companies shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Bausch Health Companies beats Aphria on 9 of the 13 factors compared between the two stocks.

Get Bausch Health Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BHC vs. The Competition

MetricBausch Health CompaniesDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$2.27BC$2.12BC$5.43BC$6.13B
Dividend Yield0.76%2.92%5.37%6.72%
P/E Ratio-12.794.0025.6246.58
Price / Sales0.34576.32374.24997.17
Price / Cash7.7610.3536.0083.29
Price / Book-13.3110.597.864.67
Net Income-C$125.65MC$21.15BC$3.15BC$301.20M
7 Day Performance6.20%2.11%1.28%0.64%
1 Month Performance40.29%7.82%5.51%4.55%
1 Year Performance-5.72%112.14%39.40%26.93%

Bausch Health Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BHC
Bausch Health Companies
N/AC$8.74
flat
N/A-6.0%C$2.27BC$6.69B-12.7919,900Analyst Revision
APHA
Aphria
N/AN/AN/AN/AC$5.24BC$611.06M-8.231,200
PBH
Premium Brands
3.1672 of 5 stars
C$80.46
+2.0%
C$101.90
+26.6%
-13.5%C$3.59BC$6.41B35.82540
AUP
Aurinia Pharmaceuticals
N/AN/AN/AN/AC$2.15BC$57.59M-11.32300High Trading Volume
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/A0.0080
SLS
Solaris Resources
1.2476 of 5 stars
C$6.05
-1.3%
C$13.83
+128.7%
+52.8%C$694.02MN/A-10.5410Analyst Forecast
CRON
Cronos Group
N/AC$2.55
-0.8%
N/A-16.7%C$673.37MC$76.86M-14.19450News Coverage
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap Up
ABT
Absolute Software Co. (ABT.TO)
N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading Volume
NOT
Noront Resources
N/AC$1.10
-0.5%
N/A+0.0%C$612.18MN/A-7.20101,700
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%
N/A+0.0%C$606.96MC$6.01M-154.0090Gap Up

Related Companies and Tools


This page (TSE:BHC) was last updated on 6/26/2025 by MarketBeat.com Staff
From Our Partners